banner

Latest News

Presentation of Research Collaboration by Frampton Lab - "Bioprinting of Three-Dimensional Mult

A recent article from Aspect Biosystems: Presentation of Research Collaboration by Frampton Lab - "Bioprinting of Three-Dimensional Multicellular Skin Constructs" Our collaborators from the Frampton Lab at Dalhousie University are presenting research they performed in collaboration with Aspect at the upcoming Skin Research Group of Сanada 5th Annual Symposium. This year, the...

Read More

AARP, startups partner to study digital healthcare technology

A recent article about Omada Health: Clinicians and groups like AARP view in-home digital technology as the future of healthcare and are studying different technologies to assist patients in the home. Research from AARP has found 90% of adults aged 50 and older use technology to stay connected. Based on that research,...Read the full article...

Read More

Lemonaid Health Raises $11M Series A

A recent article on Lemonaid Health fundraising: Lemonaid Health, a San Francisco, CA-based telehealth startup, has raised $11 million in Series A funding led by Novartis Venture Fund and Hikma Ventures and joined by Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures. Founded in 2013 by Co-Founders Ian Van Every and Paul Johnson, Lemonaid Health offers online prescr...

Read More

Curai picks up $10.7M to create a smarter system to help patients supply the best info for their doc

From Tech Crunch: Curai picks up $10.7M to create a smarter system to help patients supply the best info for their doctors  There’s been an explosion of medical startups centering their tools around machine learning to help doctors with predictive tools — and now Netflix’s former chief product officer Neil Hunt wants to enter the fray with one that hopes to get the right information f...

Read More

Omada Health Achieves Full CDC Recognition

From PR Newswire: Omada Health Achieves Full CDC RecognitionOmada Health today announced that the company has graduated to full recognition status from the Centers for Disease Control and Prevention (CDC). Omada now becomes the largest Diabetes Prevention Program (DPP) provider, in-person or virtual, to achieve full recognition from the CDC."Today's accomplishment is the culmination of wo...

Read More

Rocket Pharma's lead candidate shows positive effect in Fanconi anemia

From Seeking Alpha: Rocket Pharma's lead candidate shows positive effect in Fanconi anemia Results from a Phase 1/2 clinical trial evaluating Rocket Pharmaceuticals' (NASDAQ:RCKT) lead gene therapy candidate, RP-L102, in patients with Fanconi anemia (FA) showed a treatment effect. The data were presented at ASGCT in Chicago. Five patie...

Read More

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

From News Medical: Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research Rocket Pharmaceuticals, Inc. ("Rocket"), a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia (FA) and Pyruvate Kinase Deficiency (PKD) gene the...

Read More

Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. FDA Director as Vice Preside

From Business Wire: Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. FDA Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient AdvocacyRocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced the appointment of Gayatri R. Rao, M.D., J.D., as Vic...

Read More

Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems

From Aspect Biosystems: Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems   Vancouver, Canada — Genome BC is pleased to announce $1 million in funding to Aspect Biosystems (Aspect), a privately held biotechnology company focused on commercializing cutting-edge 3D bioprinting technologies. Aspect’s Lab-on-a-Printer™ 3D bioprinting pl...

Read More

The genomics-focused Illumina Accelerator backs five new companies including DermBiont

From TechCrunch: The genomics-focused Illumina Accelerator backs five new companies including DermBiont Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina  Corp., has picked five startups for its seventh accelerator class, the company announced.Wth technology addressing skin microbial therapeuti...

Read More